Sequence : Envelope |
Total row(s): 3 |
|---|
|
|
(You can add your comments too!) | (hover to see details) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In silico analysis of whole-genome sequences from India revealed the deletions of E protein. |
Patient data: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645280/table/tbl0005/?report=objectonly
Of the 34 sequences with E gene deletions, 15 belonged to 19A, one belonged to 19B, 4 belonged to 20A and 20B each and remaining sequences could not be categorised into any of the clades defined by Nextstrain.
C-terminal deletion in the E-gene of SARS-CoV-2 was loacated in different lineages and geographical locations (none of them had a travel history to COVID-19 infected countries) | (Virus Res)
| |||||||||||||
| Reporting multiple sequence analysis of Envelope protein (E) C-terminal domain sequence extracted from 13 genomes considered for study of SARS-CoV and SARS-CoV-2. | 2 phylogenetic clades observed with the full genome is confirmed by SARS-CoV and SARS-CoV-2 E proteins. | (Microbes Infect)
| |||||||||||||
| The mutation analysis of SARS-CoV-2 genomes from 13 different countries revealed the country-specific amino acid variations in the envelope protein. | Variations in sequences were observed when 13 SARS-CoV-2 isolates were compared to SARS-CoV sequence: Table S1: (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470274/#pone.0238344.s001) | (PLoS One)
|
Molecular_interactions : Envelope |
Total row(s): 2 |
|---|
|
|
(You can add your comments too!) | (hover to see details) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reporting the predicted model of monomeric envelope protein structure of SARS-CoV and SARS-CoV-2 | ~ | (Microbes Infect)
| |||||||||||||
| Reporting molecular binding and interaction of tight junction-associated PALS1 structure with Envelope protein C-terminal octapeptides of SARS-CoV and SARS-CoV-2 | Key role of E protein C-terminal domain during infection is emphasized. | (Microbes Infect)
|
Immunology : Envelope |
Total row(s): 7 |
|---|
|
|
(You can add your comments too!) | (hover to see details) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Out of the many B-cell 'epitopes', SRVKNL ('envelope protein') could be a possible vaccine candidate as it enables direct interactions with immune receptor. | Sequences of the SARS-CoV-2. Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686850/bin/7079356.f1.txt | (Can J Infect Dis Med Microbiol)
| |||||||||||
| These epitopes are highly antigenic, nontoxic ,and nonallergic in nature. Out of all, FLAFVVFLL and VLLFLAFVV epitopes were highly recommended as a candidate for the therapeutic peptide vaccine. | | (Can J Infect Dis Med Microbiol)
| |||||||||||
| All epitopes are antigenic and non-allergic and can induce IFN-. | | (Can J Infect Dis Med Microbiol)
| |||||||||||
| 34 cytotoxic T cell epitopes located in spike glycoprotein, envelope protein, membrane protein, and nucleocapsid phosphoprotein were identified. | | (Sci Rep)
| |||||||||||
| 14 helper T cell epitopes located in spike glycoprotein, envelope protein, and nucleocapsid phosphoprotein were identified. | | (Sci Rep)
| |||||||||||
| Eight (conserved) epitopes from envelop protein of SARS-CoV-2 were identified by in silico method. | | (Microbes Infect)
| |||||||||||
| Some of the immunogenic domains' conserved structure and mapping position were identified. | Prediction of the B-cell epitopes failed to predict epitopes sequence. | (Microbes Infect)
|